321 related articles for article (PubMed ID: 26155765)
21. Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice.
Beijers AJ; Vreugdenhil G; Oerlemans S; Eurelings M; Minnema MC; Eeltink CM; van de Poll-Franse LV; Mols F
Support Care Cancer; 2016 Jun; 24(6):2411-20. PubMed ID: 26634561
[TBL] [Abstract][Full Text] [Related]
22. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
[TBL] [Abstract][Full Text] [Related]
23. Effect of Exercise on Taxane Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer: A Randomized Controlled Trial.
Bland KA; Kirkham AA; Bovard J; Shenkier T; Zucker D; McKenzie DC; Davis MK; Gelmon KA; Campbell KL
Clin Breast Cancer; 2019 Dec; 19(6):411-422. PubMed ID: 31601479
[TBL] [Abstract][Full Text] [Related]
24. Comparative analgesic efficacy of pregabalin administered according to either a prevention protocol or an intervention protocol in rats with cisplatin-induced peripheral neuropathy.
Han FY; Kuo A; Nicholson JR; Corradinni L; Smith MT
Clin Exp Pharmacol Physiol; 2018 Oct; 45(10):1067-1075. PubMed ID: 29781509
[TBL] [Abstract][Full Text] [Related]
25. Multicenter randomized controlled trial to evaluate the efficacy and tolerability of frozen gloves for the prevention of chemotherapy-induced peripheral neuropathy.
Beijers AJM; Bonhof CS; Mols F; Ophorst J; de Vos-Geelen J; Jacobs EMG; van de Poll-Franse LV; Vreugdenhil G
Ann Oncol; 2020 Jan; 31(1):131-136. PubMed ID: 31912787
[TBL] [Abstract][Full Text] [Related]
26. Effects of Pregabalin in Patients with Neuropathic Pain Previously Treated with Gabapentin: A Pooled Analysis of Parallel-Group, Randomized, Placebo-controlled Clinical Trials.
Markman JD; Jensen TS; Semel D; Li C; Parsons B; Behar R; Sadosky AB
Pain Pract; 2017 Jul; 17(6):718-728. PubMed ID: 27611736
[TBL] [Abstract][Full Text] [Related]
27. Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study.
Solak Y; Biyik Z; Atalay H; Gaipov A; Guney F; Turk S; Covic A; Goldsmith D; Kanbay M
Nephrology (Carlton); 2012 Nov; 17(8):710-7. PubMed ID: 22909343
[TBL] [Abstract][Full Text] [Related]
28. Pregabalin for the Prevention of Oxaliplatin-Induced Painful Neuropathy: A Randomized, Double-Blind Trial.
de Andrade DC; Jacobsen Teixeira M; Galhardoni R; Ferreira KSL; Braz Mileno P; Scisci N; Zandonai A; Teixeira WGJ; Saragiotto DF; Silva V; Raicher I; Cury RG; Macarenco R; Otto Heise C; Wilson Iervolino Brotto M; Andrade de Mello A; Zini Megale M; Henrique Curti Dourado L; Mendes Bahia L; Lilian Rodrigues A; Parravano D; Tizue Fukushima J; Lefaucheur JP; Bouhassira D; Sobroza E; Riechelmann RP; Hoff PM; ; Valério da Silva F; Chile T; Dale CS; Nebuloni D; Senna L; Brentani H; Pagano RL; de Souza ÂM
Oncologist; 2017 Oct; 22(10):1154-e105. PubMed ID: 28652279
[TBL] [Abstract][Full Text] [Related]
29. [Efficacy and safety of pregabalin for oxaliplatin- and paclitaxel-induced peripheral neuropathy].
Nihei S; Sato J; Kashiwaba M; Itabashi T; Kudo K; Takahashi K
Gan To Kagaku Ryoho; 2013 Sep; 40(9):1189-93. PubMed ID: 24047777
[TBL] [Abstract][Full Text] [Related]
30. Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance for Clinical Trials in Oncology (Alliance) A151408 study data.
Smith EML; Zanville N; Kanzawa-Lee G; Donohoe C; Bridges C; Loprinzi C; Le-Rademacher J; Yang JJ
Support Care Cancer; 2019 Jul; 27(7):2599-2608. PubMed ID: 30460399
[TBL] [Abstract][Full Text] [Related]
31. Gabapentin versus pregabalin in improving sleep quality and depression in hemodialysis patients with peripheral neuropathy: a randomized prospective crossover trial.
Biyik Z; Solak Y; Atalay H; Gaipov A; Guney F; Turk S
Int Urol Nephrol; 2013 Jun; 45(3):831-7. PubMed ID: 22644743
[TBL] [Abstract][Full Text] [Related]
32. Minimal clinically important difference of the EORTC QLQ-CIPN20 for worsening peripheral neuropathy in patients receiving neurotoxic chemotherapy.
Yeo F; Ng CC; Loh KWJ; Molassiotis A; Cheng HL; Au JSK; Leung KT; Li YC; Wong KH; Suen L; Chan CW; Yorke J; Farrell C; Bandla A; Ang E; Lopez V; Sundar R; Chan A
Support Care Cancer; 2019 Dec; 27(12):4753-4762. PubMed ID: 30972646
[TBL] [Abstract][Full Text] [Related]
33. [A case of paclitaxel-induced peripheral neuropathy successfully treated with pregabalin].
Nakashima T; Kiba T; Ogawa Y; Hosokawa A; Shintani H; Okada Y; Taniguchi T; Shigeta M; Kozawa K
Gan To Kagaku Ryoho; 2012 Sep; 39(9):1443-5. PubMed ID: 22996788
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of gabapentin for the prevention of paclitaxel induced peripheral neuropathy: A randomized placebo controlled clinical trial.
Aghili M; Zare M; Mousavi N; Ghalehtaki R; Sotoudeh S; Kalaghchi B; Akrami S; Esmati E
Breast J; 2019 Mar; 25(2):226-231. PubMed ID: 30773731
[TBL] [Abstract][Full Text] [Related]
35. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.
Hershman DL; Lacchetti C; Dworkin RH; Lavoie Smith EM; Bleeker J; Cavaletti G; Chauhan C; Gavin P; Lavino A; Lustberg MB; Paice J; Schneider B; Smith ML; Smith T; Terstriep S; Wagner-Johnston N; Bak K; Loprinzi CL;
J Clin Oncol; 2014 Jun; 32(18):1941-67. PubMed ID: 24733808
[TBL] [Abstract][Full Text] [Related]
36. The Clinical Difference between Gabapentin and Pregabalin: Data from a Pilot Comparative Trial.
Gammoh O; Al-Smadi A; Shawagfeh MQ; Abadi T; Kasawneh J; Malkawi S; Zein S
Rev Recent Clin Trials; 2021; 16(3):279-287. PubMed ID: 33563173
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of oxycodone/naloxone as add-on therapy to gabapentin or pregabalin for the management of chemotherapy-induced peripheral neuropathy in Korea.
Kim BS; Jin JY; Kwon JH; Woo IS; Ko YH; Park SY; Park HJ; Kang JH
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e448-e454. PubMed ID: 29280313
[TBL] [Abstract][Full Text] [Related]
38. Pregabalin in neuropathic pain: a more "pharmaceutically elegant" gabapentin?
Guay DR
Am J Geriatr Pharmacother; 2005 Dec; 3(4):274-87. PubMed ID: 16503325
[TBL] [Abstract][Full Text] [Related]
39. Electronic versus paper-pencil methods for assessing chemotherapy-induced peripheral neuropathy.
Knoerl R; Gray E; Stricker C; Mitchell SA; Kippe K; Smith G; Dudley WN; Lavoie Smith EM
Support Care Cancer; 2017 Nov; 25(11):3437-3446. PubMed ID: 28577231
[TBL] [Abstract][Full Text] [Related]
40. The Effect of a Novel form of Extended-Release Gabapentin on Pain and Sleep in Fibromyalgia Subjects: An Open-Label Pilot Study.
North JM; Hong KS; Rauck RL
Pain Pract; 2016 Jul; 16(6):720-9. PubMed ID: 26059271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
